demonstrated a linkage between two polymorphisms that was previously confirmed in the HCV-related MC (NOTCH4 rs2071286 and HLA-II rs9461776) in patients with HCV-related lymphoproliferative disorders (LPDs) at risk of non-Hodgkin’s lymphoma (NHL) (44). This evidence concerns the gene NOTCH4 and non-Hodgkin lymphoma.